Abstract:Background: The clinical significance of miR-141-3p in hepatocellular carcinoma has not been verified. Therefore, we conducted this study to examine miR-141-3p expression and its clinical significance in hepatocellular carcinoma and to investigate the functions of its potential targets. Methods: The Cancer Genome Atlas database and the Gene Expression Omnibus database were used to explore the aberrant expression of miR-141-3p in hepatocellular carcinoma. Furthermore, we assessed the miR-141-3p levels in 95 hepatocellular carcinoma tissues with 95 matched adjacent tissues using real-time quantitative polymerase chain reaction. Moreover, a target gene prediction analysis of miR-141-3p, a natural language processing analysis for hepatocellular carcinoma using PubMed, and a gene functional enrichment analysis were conducted to search the potential function of miR-141-3p in the pathogenesis of hepatocellular carcinoma. Results: Regarding The Cancer Genome Atlas data, miR-141-3p levels were markedly downregulated in hepatocellular carcinoma tissue compared to para- or nontumor tissue (4.6112 [1.7096] vs 5.3053 [1.4254], P = .045). MiR-141-3p expression was reduced in patients with hepatocellular carcinoma with a low pathologic T stage (P = .006), a low grade (P = .01), elderly hepatocellular carcinoma patients (P = .001), and male patients with hepatocellular carcinoma (P = .01) compared with that in patients with hepatocellular carcinoma with high pathologic T stages, high grades, young patients with hepatocellular carcinoma, and female patients with hepatocellular carcinoma. However, according to the Gene Expression Omnibus database, no significant differences in the expression of miR-141-3p were observed between hepatocellular carcinoma tissue and normal liver tissue (P = .984). Real-time quantitative polymerase chain reaction confirmed a similar trend of decreased miR-141-3p in hepatocellular carcinoma tissue (1.7542 [0.8663] vs 2.5562 [1.7913], P = .001) as observed in The Cancer Genome Atlas. In addition, decreased miR-141-3p levels were detected in the multiple tumor nodes group (P = .004), the metastasis group (P < .001), and the advanced TNM stage group (P = .01), compared to the single tumor nodes group, the nonmetastasis group, and the early TNM stage group. Two hundred eighty-two genes were identified from the overlap between the predicted targets and the natural language processing analysis. Gene ontology and Kyoto Encyclopedia of Genes and Genomes pathway analyses revealed several significant biological functions and pathways related to the pathogenesis of cancers, including hepatocellular carcinoma. Conclusion: Downregulation of miR-141-3p might be responsible for the carcinogenesis and aggressiveness of hepatocellular carcinoma. MiR-141-3p may act as an antitumor microRNA, which is essential for hepatocellular carcinoma progression through the regulation of various signaling pathways. Thus, interactions with miR-141-3p may provide a novel strategy for hepatocellular carcinoma treatment in the future.

Identification of Mir-101-3p Targets and Functional Features Based on Bioinformatics, Meta-Analysis and Experimental Verification in Hepatocellular Carcinoma.

Identification of the typical miRNAs and target genes in hepatocellular carcinoma.

Clinical Value of Mir-101-3p and Biological Analysis of Its Prospective Targets in Breast Cancer: A Study Based on the Cancer Genome Atlas (TCGA) and Bioinformatics.

A Comprehensive Insight into the Clinicopathologic Significance of Mir-144-3p in Hepatocellular Carcinoma

Diagnostic Value of Strand‐specific Mirna‐101‐3p and Mirna‐101‐5p for Hepatocellular Carcinoma and a Bioinformatic Analysis of Their Possible Mechanism of Action

Downregulation of Mir-193A-3p is Involved in the Pathogenesis of Hepatocellular Carcinoma by Targeting CCND1

A Qrt-Pcr and Gene Functional Enrichment Study Focused on Downregulation of Mir-141-3p in Hepatocellular Carcinoma and Its Clinicopathological Significance

Utility of Mir‑133a‑3p As a Diagnostic Indicator for Hepatocellular Carcinoma: an Investigation Combined with GEO, TCGA, Meta‑analysis and Bioinformatics.

Mir-654-3p Predicts the Prognosis of Hepatocellular Carcinoma and Inhibits the Proliferation, Migration, and Invasion of Cancer Cells

Investigation of Mir-490-3p Expression in Hepatocellular Carcinoma Based on Reverse Transcription-Polymerase Chain Reaction (Rt-Qpcr) and a Meta-Analysis of 749 Cases.

Downregulation of Mir-199A-3p in Hepatocellular Carcinoma and Its Relevant Molecular Mechanism Via GEO, TCGA Database and in Silico Analyses

Analysis of microarrays of miR-34a and its identification of prospective target gene signature in hepatocellular carcinoma

Evaluation of Mir-302B-5p Expression and Molecular Mechanism in Hepatocellular Carcinoma: Findings Based on RT-qPCR and in Silico Analysis

Downregulation of Mir-136-5p in Hepatocellular Carcinoma and Its Clinicopathological Significance

Clinicopathological Role of Mir-30A-5p in Hepatocellular Carcinoma Tissues and Prediction of Its Function with Bioinformatics Analysis

Potential Targets and Clinical Value of Mir-490-5p in Hepatocellular Carcinoma: a Study Based on TCGA, Qrt-Pcr and Bioinformatics Analyses.

Functional Analysis of Mir-767-5p During the Progression of Hepatocellular Carcinoma and the Clinical Relevance of Its Dysregulation

Microrna-501-3p Suppresses Metastasis and Progression of Hepatocellular Carcinoma Through Targeting LIN7A.

Mir-346 Suppresses Cell Proliferation Through Smyd3 Dependent Approach in Hepatocellular Carcinoma

Identification and validation of key miRNAs and a microRNA-mRNA regulatory network associated with liver cancer

MiR-103a Promotes Tumour Growth and Influences Glucose Metabolism in Hepatocellular Carcinoma